The best characterized activating receptors that recognize ligands expressed on tumor cells are NKG2D, CD226 (also known as DNAM-1) and NCRs, which include NKp46, NKp30 and NKp44 [17,18,19]. Here, KLRK1 is linked to neoplasm.